Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2017 · 10-Q
Revenue$6.24M$6.24M+8.0% vs Q2 2016 Net Income$496.94K$496.94K−22.0% vs Q2 2016 EPS Diluted$0.06$0.06−14.3% vs Q2 2016 Operating Income$1,192,250+35.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,951,924+98.8% Margins · derivedOperating margin19.1%+3.8 pt vs Q2 2016
Net margin8.0%−3.1 pt vs Q2 2016
ended May 31, 2017 · filed Jul 7, 2017 · 37 d after period end